Barinthus Biotherapeutics (BRNS) EPS (Weighted Average and Diluted) Growth (1y) (2021 - 2026)
Barinthus Biotherapeutics (BRNS) EPS (Weighted Average and Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 251.11% |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -13.31% |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 102.51% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -79.34% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -103.05% |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 61.45% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.57 Mn | -39.54 Mn | - | 71.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.43% |
| Dec 31, 2025 | 47.06% |
| Sep 30, 2025 | -71.43% |
| Jun 30, 2025 | -20.93% |
| Mar 31, 2025 | -22.50% |
| Dec 31, 2024 | -13.33% |
| Sep 30, 2024 | 43.24% |
| Jun 30, 2024 | 30.65% |
| Mar 31, 2024 | 16.67% |
| Dec 31, 2023 | 18.18% |
| Sep 30, 2023 | -268.18% |
| Jun 30, 2023 | -251.22% |
| Mar 31, 2023 | -805.88% |
| Dec 31, 2022 | -44.74% |
| Sep 30, 2022 | 269.23% |
| Jun 30, 2022 | 164.06% |
| Mar 31, 2022 | 103.58% |
| Dec 31, 2021 | 71.21% |
| Sep 30, 2021 | -1,400.00% |